<
Pioneer and Merck build joint venture
Release time: 2011-07-29 & nbsp & nbsp & nbsp Source:

Cooperation between domestic enterprises and foreign -funded enterprises is entering a new stage。


Xianyin Pharmaceutical Group and Merck (called Merhado outside the United States and Canada) officially signed a framework cooperation agreement on July 22,It is announced that it will set up a joint venture in China,Provide high -quality drugs in important treatment fields,to meet the rapid growth of the Chinese market。


Sharing advantage products


It is understood,This cooperation will include product research and development of both parties、Registration、Manufacturing and sales and other aspects。In addition,In the early stage of cooperation, it will focus on the leading brand drugs in the field of cardiovascular and metabolic diseases。Current,The specific cooperation details of the joint venture and the scale of funds have not been disclosed,My stake betting appThe stake online sports bettingrelevant person in charge said that it will be announced in the recent press conference to announce specific matters。


According to the cooperation agreement between the two parties,The two companies will provide a selection brand and generic drug combination for the two parties in the field of cardiovascular disease,Including Merck's Shuuzhun (Siliniam)、Kosia (chorushardam) and Renitec (Elina) and Xianyin Pharmaceuticals (L -carbenzene sulfonate chlorotenpin) and Schutatin (Ruchusvas)。At the same time,The two parties will also work in the field of diabetes,Together improving the availability of Chinese diabetic patients to Sigerine。Sigerine is an innovative DPP-4 inhibitor,For the treatment of type 2 diabetes。


"Today's cooperation is an important milestone in the goal of continuously pursuing the goal of improving the quality of life by developing innovative drugs。"The Chairman and CEO of the Board of Directors of Xianyou Pharmaceutical Group Ren Jin Sheng said,"This innovative cooperation,The purpose is to respond to the huge challenge of the Chinese medical system and the needs of Chinese patients and other medical related parties。"" In his opinion,This cooperation will bring together the rich R & D of the two companies、Sales experience and resources,To achieve a goal of establishing a strategic partnership between both parties。  


New joint venture tide


Merck and the pilot's hand in hand did not make the industry too surprised,The era of new joint venture is coming。Foreign executives who frequently visit China have repeatedly passed the same information: "We are in China to seek cooperation objects。"just Stake Sports BettingMy stake betting app1 month ago,Pfizer announced the joint venture plan with Zhejiang Haizheng Pharmaceutical,The two parties intend to jointly invest 295 million US dollars to establish a joint venture。


The patented medicine that is generally encountered expired、The predicament of the price of the original drug reduction,and the opportunities and challenges brought by the implementation of the basic drug system,Let foreign companies start to adjust market strategies in China,Obtain market expansion by acquiring or joining local high -quality pharmaceutical companies; and on the other hand,Domestic corporate resources are being reviewed。"Overall more and more active,It derived from the Chinese market becoming more and more open,Business is becoming more and more mature and international,Domestic enterprises are easier to connect with overseas investors。"" Yiyan Ning, executive director of Beixiang Investment Group, thinks。In his opinion,The cooperation needs of foreign -funded enterprises are mainly reflected in: first to reduce costs,It mainly depends on China's production capacity,Make it into the entire industrial chain; the second is that there are good varieties abroad,I hope to introduce Chinese sales,This kind of company attaches great importance to the sales platform of the acquired objects in the Chinese market; the third is the demand for the new drug industry platform,I hope that the other party can have considerable research and development capabilities,Cross Chinese and Western,Not only understand the steps of Chinese research and development,can bring it to overseas research My stake betting appMy stake betting appand development concepts。


And these are the basis for reaching cooperation with Merke,Some people in the industry analyze believes that: pilot will become Merck generic drugs、Sales partner for expired patented medicine,Both parties in orthopedics、The field of lipid -lowering is overlap; the pioneer seeks Merck to help it build a research and development platform and a professional sales team;,easier to trust each other;, It is easy to accept for Merck。


"The first voice is China's leading pharmaceutical company,Merck has a common mission with the first voice,In order to promote the development of Chinese medical and health care,Able to cooperate with Xianyin Pharmaceutical,Merck is deeply proud。"Shi Yadun, president of the Ministry of Human Health, Merck Company, said,"At the same time,Cooperation is also an important step for Merck to expand its business strategy in China,This coincides with the goal of being committed to improving high -quality drugs to improve the availability of high -quality drugs。"" Facts,For Merck,According to its three -year strategic plan,Merke said before that it will launch a series of cooperation、Acquisition、Merge moves,The dilemma of improving its original market sales channels。Merck’s localization strategy is not limited to this,"The First Crab" as a foreign company,It once first entered the basic drug directory of China through the price reduction of nearly 50%of its products in foreign companies,to solve historical problems with excessive difference in the price difference between the original research drug and the price of imitation My stake betting appdrugs,stake betting appImprove its competitiveness in the grass -roots market。


The industry generally believes,Compared with the past "political marriage" with "Lang Lang",In the new joint venture wave that is expected to usher in "blowout",Foreign companies become more rational and calm,More focused on internal resource integration,Popes to strengthen the pharmaceutical business; while domestic high -quality local enterprises increase with competitiveness,It also obviously has more right to speak and negotiate chips。